# Prelude Therapeutics Inc: Form DEF 14A, filed Apr 29, 2022

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: DEF 14A
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 07:59 ET
- Period: 2022-06-17
- Accession: 0001564590-22-016626
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000156459022016626/prld-def14a_20220617.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000156459022016626/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000156459022016626/prld-def14a_20220617.htm

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-016626. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
